Chen, C. Et Al. 2022. The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS). CALCIFIED TISSUE INTERNATIONAL , vol.110, no.1 , 74-86.

Chen, C., Elsalmawy, A. H., Ish-Shalom, S., Lim, S., AlAli, N. S., Cunha-Borges, J. L., ... Yang, H.(2022). The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS). CALCIFIED TISSUE INTERNATIONAL , vol.110, no.1, 74-86.

Chen, Chung-Hwan Et Al. "The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS)," CALCIFIED TISSUE INTERNATIONAL , vol.110, no.1, 74-86, 2022

Chen, Chung-Hwan Et Al. "The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS)." CALCIFIED TISSUE INTERNATIONAL , vol.110, no.1, pp.74-86, 2022

Chen, C. Et Al. (2022) . "The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS)." CALCIFIED TISSUE INTERNATIONAL , vol.110, no.1, pp.74-86.

@article{article, author={Chung-Hwan Chen Et Al. }, title={The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS)}, journal={CALCIFIED TISSUE INTERNATIONAL}, year=2022, pages={74-86} }